 Kintara Therapeutics Inc has announced a multi-year research grant from Luxembourg National Research Fund FNR and Cancer Foundation Luxembourg to support the research of its VAL-083 program to treat glioblastoma GBM, an aggressive brain cancer. The grant has been awarded to Dr. Anna Golebiewska, who is co-leading the NORLUX Neuro-Oncology laboratory with Professor Simone Niclou at the Luxembourg Institute of Health. 